Skip to Content
s - Skip to Content
0 - Access key details
1 - Back to top
2 - Header search


New York Medicaid Prescription Drug Expenditure Trends

The Menges Group was asked to update an analysis of New York’s Medicaid prescription drug expenditure growth over the past several state fiscal years (SFY). Based on our analysis of year-over-year trends since SFY2014, we anticipate that single-digit annual growth is most likely to occur in the upcoming year. This is also in alignment with CMS nationwide estimates of Medicaid prescription drug expenditure trends.

Back to top